Be vigilant in treating a patient with diabetes and COVID-19-associated mucormycosis
Main Authors: | Pugazhenthan Thangaraju, Hemasri Velmurugan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Journal of Family Medicine and Primary Care |
Online Access: | http://www.jfmpc.com/article.asp?issn=2249-4863;year=2023;volume=12;issue=8;spage=1740;epage=1741;aulast=Thangaraju |
Similar Items
-
Gestational diabetes: Unfolded area still a concern
by: Hemasri Velmurugan, et al.
Published: (2023-01-01) -
Time to be vigilant in contacts of leprosy for possible single-dose rifampicin
by: Pugazhenthan Thangaraju, MD, et al.
Published: (2022-11-01) -
Health strategy in South State of India – Towards older people
by: Pugazhenthan Thangaraju, et al.
Published: (2023-01-01) -
SGLT-2 inhibitors: Post infarction interventional effects
by: Pugazhenthan Thangaraju, et al.
Published: (2023-03-01) -
Vigilance in Prescribing Nonsteroidal Anti-inflammatory Drugs
by: Pugazhenthan Thangaraju, et al.
Published: (2017-01-01)